1.93
전일 마감가:
$1.97
열려 있는:
$2
하루 거래량:
506.19K
Relative Volume:
1.00
시가총액:
$180.12M
수익:
$25.14M
순이익/손실:
$-21.57M
주가수익비율:
-7.1481
EPS:
-0.27
순현금흐름:
$-12.23M
1주 성능:
-12.27%
1개월 성능:
-4.93%
6개월 성능:
-32.99%
1년 성능:
+7.82%
Stereotaxis Inc Stock (STXS) Company Profile
명칭
Stereotaxis Inc
전화
314-678-6100
주소
4320 Forest Park Avenue, Suite 100, St. Louis, MO
Compare STXS vs ISRG, BDX, ALC, RMD, MDLN
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
STXS
Stereotaxis Inc
|
1.93 | 183.85M | 25.14M | -21.57M | -12.23M | -0.27 |
|
ISRG
Intuitive Surgical Inc
|
492.87 | 172.54B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
163.17 | 46.62B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
80.77 | 39.31B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
RMD
Resmed Inc
|
240.15 | 36.00B | 5.40B | 1.49B | 1.78B | 10.12 |
|
MDLN
Medline Inc
|
42.39 | 34.80B | 28.43B | 1.16B | 1.26B | 1.4457 |
Stereotaxis Inc Stock (STXS) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-16 | 개시 | Citizens JMP | Mkt Outperform |
| 2024-01-10 | 개시 | ROTH MKM | Buy |
| 2022-07-12 | 개시 | Aegis Capital | Buy |
| 2022-06-23 | 개시 | B. Riley Securities | Buy |
| 2022-01-05 | 개시 | Craig Hallum | Buy |
| 2022-01-05 | 개시 | Loop Capital | Buy |
| 2021-05-26 | 개시 | Piper Sandler | Overweight |
| 2020-09-08 | 개시 | Northland Capital | Outperform |
| 2020-04-09 | 개시 | Cowen | Outperform |
| 2020-04-07 | 개시 | Lake Street | Buy |
모두보기
Stereotaxis Inc 주식(STXS)의 최신 뉴스
Stereotaxis (STXS) Q4 Earnings: EPS Beats, Revenue Misses - GuruFocus
Stereotaxis Inc (STXS) Q4 2025 Earnings Call Highlights: Revenue Surge and Strategic Advances ... By GuruFocus - Investing.com Canada
Stereotaxis (STXS) Achieves Regulatory Milestones and Revenue Gr - GuruFocus
Stereotaxis Q4 Earnings Call Highlights - MarketBeat
Stereotaxis Inc. (STXS) Reports Q4 Loss, Lags Revenue Estimates - Bitget
Stereotaxis earnings matched, revenue fell short of estimates By Investing.com - Investing.com Canada
Stereotaxis (STXS) Projects Strong Revenue Growth by 2026 - GuruFocus
STXS Q4 Revenue Misses Expectations; Strong Backlog Reported - GuruFocus
Stereotaxis reports 20% revenue growth - The Business Journals
Surgical robotics firm Stereotaxis Q4 revenue jumps - TradingView
Stereotaxis Q4 Earnings Summary & Key Takeaways - Benzinga
Stereotaxis Reports 2025 Full Year Financial Results - GlobeNewswire
Stereotaxis, Inc. schedules Q4 and full year 2025 earnings call for 4:30 PM ET - Traders Union
Aug Weekly: Should I buy Stereotaxis Inc stock nowJuly 2025 Chart Watch & Fast Entry High Yield Tips - baoquankhu1.vn
AI Robot in Heart Treatment Market Is Going to Boom | Major Giants Intuitive Surgical, Stereotaxis, Auris Health - openPR.com
Stereotaxis (STXS) Set to Release Q4 Earnings with Revenue Growt - GuruFocus
Preview: Stereotaxis's Earnings - Benzinga
Stereotaxis Inc. (NYSEAMERICAN:STXS) Short Interest Update - Defense World
Treasury Yields: Should value investors consider Stereotaxis IncTrade Risk Summary & Low Risk Investment Opportunities - baoquankhu1.vn
Robotic technology shields patients and doctors from radiation, Stereotaxis asserts - Traders Union
Short Interest in Stereotaxis Inc. (NYSEAMERICAN:STXS) Increases By 21.2% - MarketBeat
STXSStereotaxis Reports 2022 First Quarter Financial Results - mx.advfn.com
Form S-8 POSSecurities to be offered to employees in employee benefit plans, post-effective amendments - Revista ADVFN
Stereotaxis, Inc. promotes direct experience of RoboticEP benefits through interactive demonstration - Traders Union
Stereotaxis (STXS) Projected to Release Earnings on Monday - MarketBeat
STXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Can Stereotaxis Inc. keep up with sector leadersJuly 2025 Final Week & Verified Chart Pattern Trade Signals - mfd.ru
Stereotaxis (NYSEAMERICAN:STXS) Shares Up 2.5%Still a Buy? - MarketBeat
Fed Watch: Does Stereotaxis Inc align with a passive investing strategyQuarterly Profit Report & Risk Controlled Stock Alerts - baoquankhu1.vn
Will Stereotaxis Inc. stock recover after earningsMarket Volume Summary & Safe Entry Trade Reports - mfd.ru
Why Stereotaxis Inc. stock is favored by top institutionsQuarterly Performance Summary & Community Consensus Stock Picks - mfd.ru
Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026 - GlobeNewswire
Stereotaxis announces launch of electrophysiology program at Klinikum Furth - Yahoo Finance
Will Stereotaxis Inc. stock benefit from sector rotationJuly 2025 Selloffs & Risk Adjusted Buy and Sell Alerts - mfd.ru
Stereotaxis (STXS) Launches Robotic Electrophysiology Program in Germany - GuruFocus
Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program - GlobeNewswire
Trade Recap: What are the risks of holding Stereotaxis IncMarket Activity Report & Accurate Trade Setup Notifications - baoquankhu1.vn
Stereotaxis (NYSEAMERICAN:STXS) Stock Price Down 1.6%Here's What Happened - MarketBeat
Stereotaxis Bets On New Catheters To Turn Its Niche Into Growth - Finimize
Stereotaxis Inc (STXS) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):